Yasmeen Rahimi

Stock Analyst at Piper Sandler

(3.53)
# 851
Out of 5,154 analysts
96
Total ratings
40%
Success rate
8.84%
Average return

Stocks Rated by Yasmeen Rahimi

Arcturus Therapeutics Holdings
Mar 4, 2026
Maintains: Overweight
Price Target: $72$25
Current: $7.11
Upside: +251.62%
Climb Bio
Feb 13, 2026
Initiates: Overweight
Price Target: $23
Current: $7.18
Upside: +220.33%
Korro Bio
Jan 29, 2026
Upgrades: Overweight
Price Target: $11$30
Current: $11.18
Upside: +168.34%
Praxis Precision Medicines
Jan 28, 2026
Maintains: Overweight
Price Target: $450$1,200
Current: $310.71
Upside: +286.21%
Shattuck Labs
Jan 28, 2026
Initiates: Overweight
Price Target: $15
Current: $5.99
Upside: +150.42%
BioAge Labs
Jan 27, 2026
Initiates: Overweight
Price Target: $73
Current: $20.29
Upside: +259.78%
Palisade Bio
Dec 29, 2025
Initiates: Overweight
Price Target: $25
Current: $1.63
Upside: +1,433.74%
Madrigal Pharmaceuticals
Dec 19, 2025
Maintains: Overweight
Price Target: $540$900
Current: $432.83
Upside: +107.93%
Oruka Therapeutics
Dec 18, 2025
Initiates: Overweight
Price Target: $75
Current: $32.97
Upside: +127.48%
Prothena Corporation
Oct 28, 2025
Maintains: Overweight
Price Target: $15$36
Current: $9.59
Upside: +275.39%
Initiates: Overweight
Price Target: $78
Current: $23.88
Upside: +226.63%
Initiates: Overweight
Price Target: $20
Current: $10.69
Upside: +87.09%
Initiates: Overweight
Price Target: $26
Current: $6.13
Upside: +324.14%
Maintains: Overweight
Price Target: $17$4
Current: $1.33
Upside: +200.75%
Initiates: Overweight
Price Target: $78
Current: $3.93
Upside: +1,884.73%
Maintains: Overweight
Price Target: $93$145
Current: $39.68
Upside: +265.42%
Maintains: Overweight
Price Target: $51
Current: $27.82
Upside: +83.32%
Maintains: Overweight
Price Target: $10$6
Current: $1.71
Upside: +250.88%
Initiates: Overweight
Price Target: $48
Current: $17.31
Upside: +177.30%
Initiates: Overweight
Price Target: $93
Current: $76.87
Upside: +20.98%
Initiates: Overweight
Price Target: $75
Current: $7.66
Upside: +879.11%
Initiates: Overweight
Price Target: $105
Current: $70.70
Upside: +48.51%
Reiterates: Overweight
Price Target: $37
Current: $29.86
Upside: +23.91%
Maintains: Overweight
Price Target: $26
Current: $6.97
Upside: +273.03%
Reiterates: Overweight
Price Target: $28
Current: $1.23
Upside: +2,176.42%
Maintains: Overweight
Price Target: $97
Current: $38.23
Upside: +153.73%
Initiates: Overweight
Price Target: $76
Current: $35.87
Upside: +111.88%
Maintains: Overweight
Price Target: $25
Current: $3.54
Upside: +606.21%
Initiates: Overweight
Price Target: $30
Current: $11.34
Upside: +164.55%
Upgrades: Overweight
Price Target: $6$12
Current: $10.05
Upside: +19.40%
Initiates: Overweight
Price Target: $90
Current: $6.59
Upside: +1,265.71%
Maintains: Overweight
Price Target: $15
Current: $0.50
Upside: +2,895.81%
Maintains: Overweight
Price Target: $7$16
Current: $5.27
Upside: +203.61%
Initiates: Overweight
Price Target: $80
Current: $55.41
Upside: +44.38%
Maintains: Overweight
Price Target: $58$93
Current: $57.73
Upside: +61.09%
Maintains: Overweight
Price Target: $28$57
Current: $26.66
Upside: +113.80%
Initiates: Overweight
Price Target: $67
Current: $5.41
Upside: +1,138.45%
Maintains: Overweight
Price Target: $13$20
Current: $0.82
Upside: +2,327.18%
Reiterates: Overweight
Price Target: $35
Current: $92.09
Upside: -61.99%
Maintains: Overweight
Price Target: $87
Current: $13.54
Upside: +542.54%
Maintains: Overweight
Price Target: $75$175
Current: $6.98
Upside: +2,407.16%
Maintains: Overweight
Price Target: $50$72
Current: $60.41
Upside: +19.19%
Initiates: Overweight
Price Target: $40
Current: $0.89
Upside: +4,404.50%
Initiates: Overweight
Price Target: $18
Current: $0.74
Upside: +2,337.37%
Initiates: Overweight
Price Target: $420
Current: $14.06
Upside: +2,887.20%
Initiates: Overweight
Price Target: $77
Current: $86.30
Upside: -10.78%